Disease Biology

2:11
Mass spectrometry-flow cytometry study of IgM MGUS progression to Waldenström’s
Jonas Paludo
5:26
Specific BCL2 mutation confers resistance to venetoclax in progressive CLL
Piers Blombery
2:02
Monoallelic TP53-mutated CLL patients show durable response to ibrutinib monotherapy
Carsten Niemann
1:43
Studying the genetics of CLL to prevent Richter’s transformation
Stephan Stilgenbauer
3:36
CLL-induced mitochondrial dysfunction in CD8+ T cells impedes CAR-T efficacy
Arnon Kater
2:04
Understanding risk factors for Ritcher’s transformation: addressing the unmet need
Carsten Niemann
1:50
Current ERIC research in the CLL genomics field
Richard Rosenquist
3:08
Resistance mechanisms in CLL
Richard Rosenquist
2:49
Genomic discoveries in CLL
Richard Rosenquist
2:13
CLL cell dynamics
Nicholas Chiorazzi
1:29
CpG DNA and IL-15 synergy in promoting CLL cell clonal expansion
Nicholas Chiorazzi
1:38
Therapeutically targeting transcription factors in CLL
Iñaki Martín-Subero
1:09
Integrating molecular and cellular therapies for CLL
Emili Montserrat
2:11
The role of NOTCH signaling in CLL pathogenesis
Silvia Deaglio
2:12
Complete epigenome of CLL reveals important areas of dysregulation
Iñaki Martín-Subero
1:23
The CLL epigenome
Elias Campo
The content of VJHemOnc is intended for healthcare professionals